S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Febrile Neutropenia|Stage 0 Breast Cancer|Stage 0 Colorectal Cancer|Stage 0 Non-Small Cell Lung Cancer|Stage I Colorectal Cancer|Stage IA Breast Cancer|Stage IA Non-Small Cell Lung Carcinoma|Stage IB Breast Cancer|Stage IB Non-Small Cell Lung Carcinoma|Stage IIA Breast Cancer|Stage IIA Colorectal Cancer|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Breast Cancer|Stage IIB Colorectal Cancer|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIC Colorectal Cancer|Stage IIIA Breast Cancer|Stage IIIA Colorectal Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Breast Cancer|Stage IIIB Colorectal Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IIIC Breast Cancer|Stage IIIC Colorectal Cancer|Stage IV Breast Cancer|Stage IV Non-Small Cell Lung Cancer|Stage IVA Colorectal Cancer|Stage IVB Colorectal Cancer
Interventions: OTHER: Preventive Intervention|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)|Patient-Centered Outcomes Research Institute